Future antidepressants: What is in the pipeline and what is missing?
Future antidepressants: What is in the pipeline and what is missing?
About this item
Full title
Author / Creator
Publisher
Hong Kong: Adis International
Journal title
Language
English
Formats
Publication information
Publisher
Hong Kong: Adis International
Subjects
More information
Scope and Contents
Contents
Monoamine reuptake inhibitors still reign in the treatment of major depression, but possibly not for long. While medicinal chemists have been able to reduce the side effects of these drugs, their delayed onset of action and considerable non-response rate remain problematic. Of late, serious questions have been raised regarding the efficacy of monoa...
Alternative Titles
Full title
Future antidepressants: What is in the pipeline and what is missing?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_66816706
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_66816706
Other Identifiers
ISSN
1172-7047
E-ISSN
1179-1934
DOI
10.2165/00023210-200418110-00002
